Integrating Obesity and Metabolic Management in Kidney Transplantation: A Commentary on Metoyer et al
Abstract
Vineeta Kumar, M.D.—Consulting/Advisory board → Alexion Pharmaceuticals, Vera Therapeutics, Apellis, Novartis, Memo Therapeutics and United Therapeutics. The authors have nothing to report.
Fields of Study & Subjects
Renal Transplantation Outcomes and Treatments
Dialysis and Renal Disease Management
Chronic Kidney Disease and Diabetes
Publication details
- Journal / source
- Clinical Transplantation
- Volume
- 40
- Issue
- 1
- Pages
- e70450–e70450
- Publication date
- 1 January 2026
- Language
- EN